Astec Lifesciences Employee Stock Options

Astec Lifesciences Results Update

Astec LifeSciences released a press release on its Q2 and H1 FY27 results, approved October 26, 2026. Q2 FY27 losses widened year on year.

Astec Lifesciences Other Announcement

Astec LifeSciences filed a Reg 54 Nil Security Cover certificate for its listed unsecured NCDs, stating the security cover format is not applicable. This is routine compliance paperwork with no new money or business event.

Astec Lifesciences Q2 FY27 Results: Net Loss of ₹37.4 Cr, Loss Widens

Astec Lifesciences Ltd reported revenue from operations of ₹72 Cr (-2.3% YoY) and a net loss of ₹37.4 Cr for Q2 FY27.

Key figure

Net loss ₹37.4 Cr

Astec Lifesciences Board Meeting Date

Astec LifeSciences will hold a board meeting on October 26, 2026, to consider and approve standalone and consolidated unaudited financial results for the half-year ending September 2026.

Astec Lifesciences Other Announcement

Astec Lifesciences Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as per regulatory requirements.

Astec Lifesciences Debt & Borrowing: ₹25 Cr

Astec LifeSciences Limited has redeemed Commercial Papers amounting to ₹25 Crore. The payment was made on the maturity date, 13th October, 2026.

Value

₹25.00 Cr

RateGain Travel Technologies Employee Stock Options

RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.

Execution

Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting

Aye Finance Employee Stock Options

Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.

Aarti Pharmalabs Employee Stock Options

Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.

OnEMI Technology Solutions Employee Stock Options

OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.

Bliss GVS Pharma Employee Stock Options

Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.

Bandhan Bank Employee Stock Options

Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.